Key Findings 93.4% of patients would get bariatric surgery again 51.4% of patients would consider using GLP-1 drugs again 57.1% of GLP-1 patients reported losing at least 20 pounds 98.1% of bariatric surgery patients reported losing at least 20 pounds Median weight loss for bariatric surgery patients was 100 pounds, as opposed to 20 for GLP-1s Average weight loss for bariatric surgery was reported to be 101.2, as opposed to 24.9 for GLP-1 users 93.4% of Patients Would Get Bariatric Surgery Again Out of all patients surveyed, 93.4% said they would get bariatric surgery again
On another GLP-1
Growing hair is a metabolically demanding function, so when you're in that stressed state, your body is going to shift those antigen hairs into telogen resting hairs
however, their concentrations are depleted in people with type 2 diabetess and are entirely missing in people with type 1 diabetes
If you stop the medication (especially used for weight management), weight regain is possible if lifestyle changes arent maintained
For the time being, tirzepatide remains the superior option for many people thinking about GLP-1 therapy for their obesity or type 2 diabetes, though it does tend to cost more than semaglutide